Noteworthy Price Action: After Making 52-Week High, Is Exponent, Inc.’s Near-Term Analysis Positive?

Noteworthy Price Action: After Making 52 Week High, Is Exponent, Inc.'s Near Term Analysis Positive?

The stock of Exponent, Inc. (NASDAQ:EXPO) hit a new 52-week high and has $78.15 target or 31.00% above today’s $59.66 share price. The 6 months bullish chart indicates low risk for the $1.53B company. The 1-year high was reported on Nov, 9 by Barchart.com. If the $78.15 price target is reached, the company will be worth $474.30 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 192,833 shares traded hands or 34.07% up from the average. Exponent, Inc. (NASDAQ:EXPO) has risen 18.21% since April 7, 2016 and is uptrending. It has outperformed by 13.43% the S&P500.

According to Zacks Investment Research, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors.”

Insitutional Activity: The institutional sentiment increased to 1.71 in Q2 2016. Its up 0.44, from 1.27 in 2016Q1. The ratio increased, as 12 funds sold all Exponent, Inc. shares owned while 39 reduced positions. 19 funds bought stakes while 68 increased positions. They now own 23.37 million shares or 1.97% more from 22.92 million shares in 2016Q1.
Tiverton Asset Limited Liability last reported 0.71% of its portfolio in the stock. Blackrock Grp Ltd holds 0% of its portfolio in Exponent, Inc. (NASDAQ:EXPO) for 40,382 shares. Raymond James And Associate holds 78,968 shares or 0.01% of its portfolio. Proshare Advisors Ltd Co last reported 3,711 shares in the company. Gemmer Asset Management Ltd Liability, a California-based fund reported 92 shares. Roffman Miller Inc Pa accumulated 1.27% or 132,122 shares. New York State Teachers Retirement holds 24,314 shares or 0% of its portfolio. Tompkins Fincl holds 0% or 65 shares in its portfolio. Envestnet Asset Mgmt has 36,262 shares for 0.01% of their US portfolio. Moreover, Deutsche Commercial Bank Ag has 0% invested in Exponent, Inc. (NASDAQ:EXPO) for 64,070 shares. Mackenzie Financial, a Ontario – Canada-based fund reported 7,064 shares. Ubs Asset Management Americas owns 51,757 shares or 0% of their US portfolio. Rice Hall James Assoc Ltd has 0.15% invested in the company for 43,672 shares. First Tru Lp reported 45,379 shares or 0.01% of all its holdings. Aqr Capital Ltd last reported 0% of its portfolio in the stock.

Insider Transactions: Since May 11, 2016, the stock had 0 insider buys, and 20 selling transactions for $5.67 million net activity. Shares for $277,148 were sold by JOHNSTON PAUL R. 3,000 shares were sold by Corrigan Catherine, worth $158,040 on Friday, May 27. Another trade for 342 shares valued at $19,501 was made by Murray Steven J on Monday, October 24. SCHLENKER RICHARD L JR also sold $829,491 worth of Exponent, Inc. (NASDAQ:EXPO) on Tuesday, October 25. On Monday, May 16 Boehm Paul sold $510,000 worth of the stock or 10,000 shares. Shares for $67,172 were sold by CALIGIURI ROBERT D on Friday, August 12. Another trade for 2,386 shares valued at $135,882 was sold by RIGGINS STEPHEN C.

More recent Exponent, Inc. (NASDAQ:EXPO) news were published by: Streetinsider.com which released: “Exponent, Inc. (EXPO) Reports In-Line Q2 EPS; Trims Outlook” on July 19, 2016. Also Nasdaq.com published the news titled: “Exponent Inc. (EXPO) Has Jumped To A 3-Month High Following Q3 Report” on October 20, 2016. Streetinsider.com‘s news article titled: “Exponent, Inc. (EXPO) Tops Q3 EPS by 8c, Comments on Outlook” with publication date: October 19, 2016 was also an interesting one.

EXPO Company Profile

Exponent, Inc. (Exponent), incorporated on May 9, 1989, along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. The Company’s service offerings are provided on a project-by-project basis. It operates over 20 practices and centers in two operating divisions: Engineering and Other Scientific, and Environmental and Health. The Company’s Engineering and Other Scientific segment includes biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, engineering management consulting, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, technology development, thermal sciences and vehicle analysis services. The Company’s Environmental and Health segment includes chemical regulation and food safety; ecological and biological sciences; environmental and earth sciences; epidemiology, biostatistics and computational biology; occupational and environmental health risk assessment, and toxicology and mechanistic biology. Exponent serves clients in automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing and technology, among others.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment